Please use this identifier to cite or link to this item: http://ir.mu.ac.ke:8080/jspui/handle/123456789/3543
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLoiseau, Chloé-
dc.contributor.authorBrites, Daniela-
dc.contributor.authorReinhard, Miriam-
dc.contributor.authorZürcher, Kathrin-
dc.contributor.authorBorrell, Sonia-
dc.contributor.authorBallif, Marie-
dc.contributor.authorFenner, Lukas-
dc.contributor.authorCox, Helen-
dc.contributor.authorRutaihwa, Liliana K.-
dc.contributor.authorWilkinson, Robert J.-
dc.contributor.authorYotebieng, Marcel-
dc.contributor.authorCarter, E. Jane-
dc.contributor.authorAlash’le, Abimiku-
dc.contributor.authorOlivier, Marcy-
dc.date.accessioned2020-10-14T07:07:38Z-
dc.date.available2020-10-14T07:07:38Z-
dc.date.issued2020-
dc.identifier.urihttps://aac.asm.org/content/64/10/e00782-20-
dc.identifier.urihttp://ir.mu.ac.ke:8080/jspui/handle/123456789/3543-
dc.description.abstractWe analyzed 312 drug-resistant genomes of Mycobacterium tuberculosis isolates collected from HIV-coinfected and HIV-negative TB patients from nine countries with a high tuberculosis burden. We found that rifampicin-resistant M. tuberculosis strains isolated from HIV-coinfected patients carried disproportionally more resistance-conferring mutations in rpoB that are associated with a low fitness in the absence of the drug, suggesting these low-fitness rpoB variants can thrive in the context of reduced host immunity.en_US
dc.language.isoenen_US
dc.publisherAmerican Societyen_US
dc.subjectHIV-TB coinfectionen_US
dc.subjectMycobacterium tuberculosisen_US
dc.subjectDrug resistanceen_US
dc.subjectFitness costen_US
dc.subjectrifampicinen_US
dc.titleHIV coinfection is associated with low-fitness rpoB variants in Rifampicin-resistant mycobacterium tuberculosisen_US
dc.typeArticleen_US
Appears in Collections:School of Medicine

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.